Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167

Watchlist Manager
Jacobio Pharmaceuticals Group Co Ltd Logo
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
Watchlist
Price: 1.68 HKD -1.18%
Market Cap: 1.3B HKD
Have any thoughts about
Jacobio Pharmaceuticals Group Co Ltd?
Write Note

Jacobio Pharmaceuticals Group Co Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jacobio Pharmaceuticals Group Co Ltd
Other Current Liabilities Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
Other Current Liabilities
ÂĄ36m
CAGR 3-Years
85%
CAGR 5-Years
119%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Other Current Liabilities
ÂĄ1.5B
CAGR 3-Years
-7%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Other Current Liabilities
ÂĄ1.9B
CAGR 3-Years
53%
CAGR 5-Years
54%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Other Current Liabilities
ÂĄ343.5m
CAGR 3-Years
27%
CAGR 5-Years
12%
CAGR 10-Years
27%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Other Current Liabilities
ÂĄ2.5B
CAGR 3-Years
19%
CAGR 5-Years
74%
CAGR 10-Years
62%
Imeik Technology Development Co Ltd
SZSE:300896
Other Current Liabilities
ÂĄ121.8m
CAGR 3-Years
33%
CAGR 5-Years
72%
CAGR 10-Years
N/A

See Also

What is Jacobio Pharmaceuticals Group Co Ltd's Other Current Liabilities?
Other Current Liabilities
36m CNY

Based on the financial report for Dec 31, 2023, Jacobio Pharmaceuticals Group Co Ltd's Other Current Liabilities amounts to 36m CNY.

What is Jacobio Pharmaceuticals Group Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
119%

Over the last year, the Other Current Liabilities growth was 496%. The average annual Other Current Liabilities growth rates for Jacobio Pharmaceuticals Group Co Ltd have been 85% over the past three years , 119% over the past five years .

Back to Top